{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:57:51Z","timestamp":1775167071267,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/2011\/78184"],"award-info":[{"award-number":["SFRH\/BD\/2011\/78184"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/74307\/2010"],"award-info":[{"award-number":["SFRH\/BD\/74307\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2228-y","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T03:31:45Z","timestamp":1457148705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Local iron homeostasis in the breast ductal carcinoma microenvironment"],"prefix":"10.1186","volume":"16","author":[{"given":"Oriana","family":"Marques","sequence":"first","affiliation":[]},{"given":"Gra\u00e7a","family":"Porto","sequence":"additional","affiliation":[]},{"given":"Alexandra","family":"R\u00eama","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Faria","sequence":"additional","affiliation":[]},{"given":"Arnaud","family":"Cruz Paula","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Gomez-Lazaro","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Berta","family":"Martins da Silva","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Lopes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,3,5]]},"reference":[{"key":"2228_CR1","unstructured":"Ferlay J SI, Ervik M, Dkshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. In: IARC CancerBase. International Agency for Research on Cancer, Lyon, France. 2013. http:\/\/globocan.iarc.fr . Accessed 20-09-2014 2014."},{"key":"2228_CR2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbagen.2008.04.003","volume":"1790","author":"DR Richardson","year":"2009","unstructured":"Richardson DR, Kalinowski DS, Lau S, Jansson PJ, Lovejoy DB. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta. 2009;1790:702\u201317.","journal-title":"Biochim Biophys Acta"},{"key":"2228_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/carcin\/12.1.111","volume":"12","author":"HJ Thompson","year":"1991","unstructured":"Thompson HJ, Kennedy K, Witt M, Juzefyk J. Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis. 1991;12:111\u20134.","journal-title":"Carcinogenesis."},{"key":"2228_CR4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/carcin\/15.8.1567","volume":"15","author":"M Singh","year":"1994","unstructured":"Singh M, Lu J, Briggs SP, McGinley JN, Haegele AD, Thompson HJ. Effect of excess dietary iron on the promotion stage of 1-methyl-1-nitrosourea-induced mammary carcinogenesis: pathogenetic characteristics and distribution of iron. Carcinogenesis. 1994;15:1567\u201370.","journal-title":"Carcinogenesis."},{"key":"2228_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/01635589509514401","volume":"24","author":"D Hrabinski","year":"1995","unstructured":"Hrabinski D, Hertz JL, Tantillo C, Berger V, Sherman AR. Iron repletion attenuates the protective effects of iron deficiency in DMBA-induced mammary tumors in rats. Nutr Cancer. 1995;24:133\u201342.","journal-title":"Nutr Cancer."},{"key":"2228_CR6","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/carcin\/18.9.1757","volume":"18","author":"BA Diwan","year":"1997","unstructured":"Diwan BA, Kasprzak KS, Anderson LM. Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague\u2013Dawley rats. Carcinogenesis. 1997;18:1757\u201362.","journal-title":"Carcinogenesis."},{"key":"2228_CR7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1470-2045(08)70200-6","volume":"9","author":"X Huang","year":"2008","unstructured":"Huang X. Does iron have a role in breast cancer? Lancet Oncol. 2008;9:803\u20137.","journal-title":"Lancet Oncol."},{"key":"2228_CR8","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1158\/1055-9965.EPI-07-0187","volume":"16","author":"Y Cui","year":"2007","unstructured":"Cui Y, Vogt S, Olson N, Glass AG, Rohan TE. Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1682\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2228_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.1993.tb17204.x","volume":"698","author":"RL Elliott","year":"1993","unstructured":"Elliott RL, Elliott MC, Wang F, Head JF. Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann N Y Acad Sci. 1993;698:159\u201366.","journal-title":"Ann N Y Acad Sci"},{"key":"2228_CR10","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1158\/0008-5472.CAN-11-1870","volume":"71","author":"LD Miller","year":"2011","unstructured":"Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D'Agostino Jr R, et al. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 2011;71:6728\u201337.","journal-title":"Cancer Res."},{"key":"2228_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-010-0849-4","volume":"126","author":"SI Shpyleva","year":"2011","unstructured":"Shpyleva SI, Tryndyak VP, Kovalchuk O, Starlard-Davenport A, Chekhun VF, Beland FA, et al. Role of ferritin alterations in human breast cancer cells. Breast Cancer Res Treat. 2011;126:63\u201371.","journal-title":"Breast Cancer Res Treat."},{"key":"2228_CR12","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.cellsig.2014.07.029","volume":"26","author":"S Zhang","year":"2014","unstructured":"Zhang S, Chen Y, Guo W, Yuan L, Zhang D, Xu Y, et al. Disordered hepcidin-ferroportin signaling promotes breast cancer growth. Cell Signal. 2014;26:2539\u201350.","journal-title":"Cell Signal."},{"key":"2228_CR13","doi-asserted-by":"crossref","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","volume":"2","author":"ZK Pinnix","year":"2010","unstructured":"Pinnix ZK, Miller LD, Wang W, D'Agostino Jr R, Kute T, Willingham MC, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010;2:43ra56.","journal-title":"Sci Transl Med"},{"key":"2228_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1189\/jlb.1107762","volume":"84","author":"JW Pollard","year":"2008","unstructured":"Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 2008;84:623\u201330.","journal-title":"J Leukoc Biol."},{"key":"2228_CR15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr1746","volume":"9","author":"DG DeNardo","year":"2007","unstructured":"DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res. 2007;9:212.","journal-title":"Breast Cancer Res"},{"key":"2228_CR16","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1073\/pnas.1104303108","volume":"109","author":"B Ruffell","year":"2012","unstructured":"Ruffell B, Au A, Rugo HS, Esserman LJ, Hwang ES, Coussens LM. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796\u2013801.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2228_CR17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"MJ Bissell","year":"2011","unstructured":"Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011;17:320\u20139.","journal-title":"Nat Med."},{"key":"2228_CR18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344.","journal-title":"Nature."},{"key":"2228_CR19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0090-1229(83)90061-2","volume":"27","author":"MS Pollack","year":"1983","unstructured":"Pollack MS, da Silva BM, Moshief RD, Groshen S, Bognacki J, Dupont B, et al. Ferritin secretion by human mononuclear cells: association with HLA phenotype. Clin Immunol Immunopathol. 1983;27:124\u201334.","journal-title":"Clin Immunol Immunopathol."},{"key":"2228_CR20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.6967622","volume":"209","author":"MH Dorner","year":"1980","unstructured":"Dorner MH, Silverstone A, Nishiya K, de Sostoa A, Munn G, de Sousa M. Ferritin synthesis by human T lymphocytes. Science. 1980;209:1019\u201321.","journal-title":"Science."},{"key":"2228_CR21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10549-012-2405-x","volume":"137","author":"AA Alkhateeb","year":"2013","unstructured":"Alkhateeb AA, Han B, Connor JR. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat. 2013;137:733\u201344.","journal-title":"Breast Cancer Res Treat."},{"key":"2228_CR22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ijc.26397","volume":"131","author":"P Jezequel","year":"2012","unstructured":"Jezequel P, Campion L, Spyratos F, Loussouarn D, Campone M, Guerin-Charbonnel C, et al. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study. Int J Cancer. 2012;131:426\u201337.","journal-title":"Int J Cancer."},{"key":"2228_CR23","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3324\/haematol.2010.023879","volume":"95","author":"G Corna","year":"2010","unstructured":"Corna G, Campana L, Pignatti E, Castiglioni A, Tagliafico E, Bosurgi L, et al. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica. 2010;95:1814\u201322.","journal-title":"Haematologica."},{"key":"2228_CR24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/eji.200939889","volume":"40","author":"S Recalcati","year":"2010","unstructured":"Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M, et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol. 2010;40:824\u201335.","journal-title":"Eur J Immunol."},{"key":"2228_CR25","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood-2011-07-366690","volume":"119","author":"DY Shin","year":"2012","unstructured":"Shin DY, Chung J, Joe Y, Pae HO, Chang KC, Cho GJ, et al. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways. Blood. 2012;119:2523\u201332.","journal-title":"Blood."},{"key":"2228_CR26","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-14-2465","volume":"75","author":"L Tesfay","year":"2015","unstructured":"Tesfay L, Clausen KA, Kim JW, Hegde P, Wang X, Miller LD, et al. Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer. Cancer Res. 2015;75:2254\u201363.","journal-title":"Cancer Res."},{"key":"2228_CR27","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.M803005200","volume":"283","author":"ML Wallander","year":"2008","unstructured":"Wallander ML, Zumbrennen KB, Rodansky ES, Romney SJ, Leibold EA. Iron-independent phosphorylation of iron regulatory protein 2 regulates ferritin during the cell cycle. J Biol Chem. 2008;283:23589\u201398.","journal-title":"J Biol Chem."},{"key":"2228_CR28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e31821247a8","volume":"35","author":"HY Dong","year":"2011","unstructured":"Dong HY, Wilkes S, Yang HS. CD71 is Selectively and Ubiquitously Expressed at High Levels in Erythroid Precursors of All Maturation Stages: A Comparative Immunochemical Study With Glycophorin A and Hemoglobin A. Am J Surg Pathol. 2011;35:723\u201332.","journal-title":"Am J Surg Pathol."},{"key":"2228_CR29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","volume":"316","author":"K Pietras","year":"2010","unstructured":"Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316:1324\u201331.","journal-title":"Exp Cell Res."},{"key":"2228_CR30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-012-2123-4","volume":"135","author":"AC Vargas","year":"2012","unstructured":"Vargas AC, McCart Reed AE, Waddell N, Lane A, Reid LE, Smart CE, et al. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat. 2012;135:153\u201365.","journal-title":"Breast Cancer Res Treat."},{"key":"2228_CR31","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14:1014\u201322.","journal-title":"Nat Immunol."},{"key":"2228_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","volume":"4","author":"G Dranoff","year":"2004","unstructured":"Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11\u201322.","journal-title":"Nat Rev Cancer."},{"key":"2228_CR33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","volume":"9","author":"JW Pollard","year":"2009","unstructured":"Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009;9:259\u201370.","journal-title":"Nat Rev Immunol."},{"key":"2228_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","volume":"522","author":"SB Coffelt","year":"2015","unstructured":"Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau C-S, et al. IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522:345\u20138.","journal-title":"Nature."},{"key":"2228_CR35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182\u20136.","journal-title":"N Engl J Med."},{"key":"2228_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/187152808784165162","volume":"7","author":"MF Macedo","year":"2008","unstructured":"Macedo MF, de Sousa M. Transferrin and the transferrin receptor: of magic bullets and other concerns. Inflamm Allergy Drug Targets. 2008;7:41\u201352.","journal-title":"Inflamm Allergy Drug Targets."},{"key":"2228_CR37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cellsig.2014.11.002","volume":"27","author":"Y Chen","year":"2015","unstructured":"Chen Y, Zhang S, Wang X, Guo W, Wang L, Zhang D, et al. Disordered signaling governing ferroportin transcription favors breast cancer growth. Cell Signal. 2015;27:168\u201376.","journal-title":"Cell Signal."},{"key":"2228_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/0008-5472.CAN-13-1224","volume":"74","author":"W Wang","year":"2014","unstructured":"Wang W, Deng Z, Hatcher H, Miller LD, Di X, Tesfay L, et al. IRP2 regulates breast tumor growth. Cancer Res. 2014;74:497\u2013507.","journal-title":"Cancer Res."},{"key":"2228_CR39","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1053\/j.gastro.2011.03.007","volume":"140","author":"M Taylor","year":"2011","unstructured":"Taylor M, Qu A, Anderson ER, Matsubara T, Martin A, Gonzalez FJ, et al. Hypoxia-inducible factor-2alpha mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology. 2011;140:2044\u201355.","journal-title":"Gastroenterology."},{"key":"2228_CR40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4049\/jimmunol.136.2.532","volume":"136","author":"B Manger","year":"1986","unstructured":"Manger B, Weiss A, Hardy KJ, Stobo JD. A transferrin receptor antibody represents one signal for the induction of IL 2 production by a human T cell line. J Immunol. 1986;136:532\u20138.","journal-title":"J Immunol."},{"key":"2228_CR41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4049\/jimmunol.144.2.765","volume":"144","author":"DM Paulnock","year":"1990","unstructured":"Paulnock DM, Lambert LE. Identification and Characterization of Monoclonal-Antibodies Specific for Macrophages at Intermediate Stages in the Tumoricidal Activation Pathway. J Immunol. 1990;144:765\u201373.","journal-title":"J Immunol."},{"key":"2228_CR42","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1073\/pnas.0409409102","volume":"102","author":"MD Knutson","year":"2005","unstructured":"Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A. 2005;102:1324\u20138.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2228_CR43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/BJ20071474","volume":"411","author":"C Delaby","year":"2008","unstructured":"Delaby C, Pilard N, Puy H, Canonne-Hergaux F. Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem J. 2008;411:123\u201331.","journal-title":"Biochem J."},{"key":"2228_CR44","doi-asserted-by":"crossref","first-page":"e76147","DOI":"10.1371\/journal.pone.0076147","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Cheng SQ, Zhang MY, Zhen LN, Pang D, Zhang QY, et al. High-Infiltration of Tumor-Associated Macrophages Predicts Unfavorable Clinical Outcome for Node-Negative Breast Cancer. PLoS ONE. 2013;8:e76147.","journal-title":"PLoS ONE."},{"key":"2228_CR45","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","volume":"29","author":"SMA Mahmoud","year":"2011","unstructured":"Mahmoud SMA, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AHS, et al. Tumor-Infiltrating CD8(+) Lymphocytes Predict Clinical Outcome in Breast Cancer. J Clin Oncol. 2011;29:1949\u201355.","journal-title":"J Clin Oncol."},{"key":"2228_CR46","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1186\/bcr3148","volume":"14","author":"SZ Liu","year":"2012","unstructured":"Liu SZ, Lachapelle J, Leung S, Gao DX, Foulkes WD, Nielsen TO. CD8(+) lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Res. 2012;14:R48.","journal-title":"Breast Cancer Res."},{"key":"2228_CR47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/bjc.1986.174","volume":"54","author":"KJ Britten","year":"1986","unstructured":"Britten KJ, Jones DB, De Sousa M, Wright DH. The distribution of iron and iron binding proteins in spleen with reference to Hodgkin's disease. Br J Cancer. 1986;54:277\u201386.","journal-title":"Br J Cancer."},{"key":"2228_CR48","doi-asserted-by":"crossref","first-page":"e79870","DOI":"10.1371\/journal.pone.0079870","volume":"8","author":"J Arezes","year":"2013","unstructured":"Arezes J, Costa M, Vieira I, Dias V, Kong XL, Fernandes R, et al. Non-Transferrin-Bound Iron (NTBI) Uptake by T Lymphocytes: Evidence for the Selective Acquisition of Oligomeric Ferric Citrate Species. PLoS ONE. 2013;8:e79870.","journal-title":"PLoS ONE."},{"key":"2228_CR49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2014.00024","volume":"5","author":"JP Pinto","year":"2014","unstructured":"Pinto JP, Arezes J, Dias V, Oliveira S, Vieira I, Costa M, et al. Physiological implications of NTBI uptake by T lymphocytes. Front Pharmacol. 2014;5:24.","journal-title":"Front Pharmacol."},{"key":"2228_CR50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.physiol.69.031905.164337","volume":"69","author":"NC Andrews","year":"2007","unstructured":"Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69\u201385.","journal-title":"Annu Rev Physiol."},{"key":"2228_CR51","volume-title":"Lymphocyte circulation: experimental and clinical aspects","author":"M Sousa de","year":"1981","unstructured":"de Sousa M. Lymphocyte circulation: experimental and clinical aspects. New York: John Wiley and Sons; 1981."},{"key":"2228_CR52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1039\/C0IB00116C","volume":"3","author":"M Sousa de","year":"2011","unstructured":"de Sousa M. An outsider's perspective--ecotaxis revisited: an integrative review of cancer environment, iron and immune system cells. Integr Biol. 2011;3:343\u20139.","journal-title":"Integr Biol."},{"key":"2228_CR53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-009-0654-0","volume":"123","author":"M Sharma","year":"2010","unstructured":"Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, et al. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Res Treat. 2010;123:397\u2013404.","journal-title":"Breast Cancer Res Treat."},{"key":"2228_CR54","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr2222","volume":"11","author":"XJ Ma","year":"2009","unstructured":"Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009;11:R7.","journal-title":"Breast Cancer Res."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2228-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:49:56Z","timestamp":1692244196000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/16\/187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,5]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2228-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,5]]},"article-number":"187"}}